Skip to main content

Concerns on Vaccine against Varicella Caused by Varicella-Zoster Virus Infection

This is a preview of subscription content, access via your institution.

References

  • Argoff CE, Katz N, Backonja M (2004) Treatment of postherpetic neuralgia: a review of therapeutic options. J Pain Symptom Manage 28:396–411

    Article  PubMed  Google Scholar 

  • Arvin AM (2013) Varicella-zoster virus. Fileds virology, 6th edn. Wolters Kluwer Health, Philadelphia

    Google Scholar 

  • Asano Y, Itakura N, Hiroishi Y, Hirose S, Ozaki T, Kuno K, Nagai T, Yazaki T, Yamanishi K, Takahashi M (1985) Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients. J Infect Dis 152:863–868

    Article  CAS  PubMed  Google Scholar 

  • Asano Y, Suga S, Yoshikawa T, Kobayashi I, Yazaki T, Shibata M, Tsuzuki K, Ito S (1994) Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine. Pediatrics 94:524–526

    CAS  PubMed  Google Scholar 

  • Cunningham AL, Lal H, Kovac M, Chlibek R, Hwang SJ, Diez-Domingo J, Godeaux O, Levin MJ, McElhaney JE, Puig-Barbera J, Van den Abeele C, Vesikari T, Watanabe D, Zahaf T, Ahonen A, Athan E, Barba-Gomez JF, Campora L, de Looze F, Downey HJ, Ghesquiere W, Gorfinkel I, Korhonen T, Leung E, McNeil SA, Oostvogels L, Rombo L, Smetana J, Weckx L, Yeo W, Heineman TC, Group ZOES (2016) Efficacy of the Herpes Zoster subunit vaccine in adults 70 years of age or older. N Engl J Med 375:1019–1032

    Article  CAS  PubMed  Google Scholar 

  • Deng X, Xu W, Yan R, Chen H, Shen W, Zhang M, Wu T, Xu B, He H, Ma Y (2016) Immunogenicity and safety of different schedules of 2-dose varicella vaccination in China. Hum Vaccin Immunother 12:3113–3117

    Article  PubMed  PubMed Central  Google Scholar 

  • Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Mansfield K, Minassian C, Langan SM (2016) Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: a cohort study. Neurology 87:94–102

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Galea SA, Sweet A, Beninger P, Steinberg SP, Larussa PS, Gershon AA, Sharrar RG (2008) The safety profile of varicella vaccine: a 10-year review. J Infect Dis 197(Suppl 2):S165–169

    Article  PubMed  Google Scholar 

  • Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, Grose C, Hambleton S, Kennedy PG, Oxman MN, Seward JF, Yamanishi K (2015) Varicella zoster virus infection. Nat Rev Dis Primers 1:15016

    Article  PubMed  PubMed Central  Google Scholar 

  • Jeon YH (2015) Herpes zoster and postherpetic neuralgia: practical consideration for prevention and treatment. Korean J Pain 28:177–184

    Article  PubMed  PubMed Central  Google Scholar 

  • Jiang HF, Wang W, Jiang X, Zeng WB, Shen ZZ, Song YG, Yang H, Liu XJ, Dong X, Zhou J, Sun JY, Yu FL, Guo L, Cheng T, Rayner S, Zhao F, Zhu H, Luo MH (2017) ORF7 of varicella-zoster virus is required for viral cytoplasmic envelopment in differentiated neuronal cells. J Virol 91:e00127

    CAS  PubMed  PubMed Central  Google Scholar 

  • Johnson BH, Palmer L, Gatwood J, Lenhart G, Kawai K, Acosta CJ (2015a) Annual incidence rates of herpes zoster among an immunocompetent population in the United States. BMC Infect Dis 15:502

    Article  PubMed  PubMed Central  Google Scholar 

  • Johnson RW, Alvarez-Pasquin MJ, Bijl M, Franco E, Gaillat J, Clara JG, Labetoulle M, Michel JP, Naldi L, Sanmarti LS, Weinke T (2015b) Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective. Ther Adv Vaccines 3:109–120

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, Levin MJ, McElhaney JE, Poder A, Puig-Barbera J, Vesikari T, Watanabe D, Weckx L, Zahaf T, Heineman TC, Group ZOES (2015) Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med 372:2087–2096

    Article  PubMed  Google Scholar 

  • Lo L, Anderson DJ (2011) A Cre-dependent, anterograde transsynaptic viral tracer for mapping output pathways of genetically marked neurons. Neuron 72:938–950

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Miranda-Saksena M, Boadle RA, Diefenbach RJ, Cunningham AL (2015) Dual role of herpes simplex virus 1 pUS9 in virus anterograde axonal transport and final assembly in growth cones in distal axons. J Virol 90:2653–2663

    Article  PubMed  Google Scholar 

  • Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW Jr, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL, Shingles Prevention Study Group (2005) A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352:2271–2284

    Article  CAS  PubMed  Google Scholar 

  • Pan X, Shu M, Ma R, Fang T, Dong H, Sun Y, Xu G (2018) Varicella breakthrough infection and effectiveness of 2-dose varicella vaccine in China. Vaccine 36:5665–5670

    Article  PubMed  Google Scholar 

  • Pastuszak AL, Levy M, Schick B, Zuber C, Feldkamp M, Gladstone J, Bar-Levy F, Jackson E, Donnenfeld A, Meschino W et al (1994) Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med 330:901–905

    Article  CAS  PubMed  Google Scholar 

  • Schmader KE, Levin MJ, Gnann JW Jr, McNeil SA, Vesikari T, Betts RF, Keay S, Stek JE, Bundick ND, Su SC, Zhao Y, Li X, Chan IS, Annunziato PW, Parrino J (2012) Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50–59 years. Clin Infect Dis 54:922–928

    Article  PubMed  PubMed Central  Google Scholar 

  • Schuster V, Otto W, Maurer L, Tcherepnine P, Pfletschinger U, Kindler K, Soemantri P, Walther U, Macholdt U, Douha M, Pierson P, Willems P (2008) Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life. Pediatr Infect Dis J 27:724–730

    Article  PubMed  Google Scholar 

  • Selariu A, Cheng T, Tang Q, Silver B, Yang L, Liu C, Ye X, Markus A, Goldstein RS, Cruz-Cosme RS, Lin Y, Wen L, Qian H, Han J, Dulal K, Huang Y, Li Y, Xia N, Zhu H (2012) ORF7 of varicella-zoster virus is a neurotropic factor. J Virol 86:8614–8624

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T (1974) Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 2:1288–1290

    Article  CAS  PubMed  Google Scholar 

  • Weibel RE, Neff BJ, Kuter BJ, Guess HA, Rothenberger CA, Fitzgerald AJ, Connor KA, McLean AA, Hilleman MR, Buynak EB et al (1984) Live attenuated varicella virus vaccine. Efficacy trial in healthy children. N Engl J Med 310:1409–1415

    Article  CAS  PubMed  Google Scholar 

  • Weinmann S, Chun C, Schmid DS, Roberts M, Vandermeer M, Riedlinger K, Bialek SR, Marin M (2013) Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005–2009. J Infect Dis 208:1859–1868

    Article  PubMed  Google Scholar 

  • Whitley RJ, Volpi A, McKendrick M, Wijck A, Oaklander AL (2010) Management of herpes zoster and post-herpetic neuralgia now and in the future. J Clin Virol 48(Suppl 1):S20–28

    Article  CAS  PubMed  Google Scholar 

  • Woodward M, Marko A, Galea S, Eagel B, Straus W (2019) Varicella virus vaccine live: a 22-year review of postmarketing safety data. Open forum infectious diseases. Oxford University Press, Oxford

    Google Scholar 

  • Wu QS, Wang X, Liu JY, Chen YF, Zhou Q, Wang Y, Sha JD, Xuan ZL, Zhang LW, Yan L, Hu Y (2019) Varicella outbreak trends in school settings during the voluntary single-dose vaccine era from 2006 to 2017 in Shanghai, China. Int J Infect Dis 89:72–78

    Article  PubMed  Google Scholar 

  • Yoshikawa T, Ando Y, Nakagawa T, Gomi Y (2016) Safety profile of the varicella vaccine (Oka vaccine strain) based on reported cases from 2005 to 2015 in Japan. Vaccine 34:4943–4947

    Article  CAS  PubMed  Google Scholar 

  • Zeng WB, Jiang HF, Gang YD, Song YG, Shen ZZ, Yang H, Dong X, Tian YL, Ni RJ, Liu Y, Tang N, Li X, Jiang X, Gao D, Androulakis M, He XB, Xia HM, Ming YZ, Lu Y, Zhou JN, Zhang C, Xia XS, Shu Y, Zeng SQ, Xu F, Zhao F, Luo MH (2017) Anterograde monosynaptic transneuronal tracers derived from herpes simplex virus 1 strain H129. Mol Neurodegener 12:38

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Hongjie Shen or Min-Hua Luo.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Animal and Human Rights Statement

This article does not contain any studies with human or animal subjects performed by any of the authors.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zeng, WB., Zhang, F., Cheng, S. et al. Concerns on Vaccine against Varicella Caused by Varicella-Zoster Virus Infection. Virol. Sin. 36, 159–162 (2021). https://doi.org/10.1007/s12250-020-00231-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12250-020-00231-4